KCNA5 and pulmonary arterial hypertension: Similar results were obtained in vivo using cyclosporine A, with inhibition of NFATc2 reversing MCT-induced PAH by increasing expression of Kv1.5, reducing Bcl-2 levels and promoting mitochondrial-dependent apoptosis.